In one report, a subpopulation of vascular progenitor cells (VEGFR2+ CD31− CD34−) harboring the BCR/ABL gene fusion was identified in the BM of patients with CML [31]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.